ATE184489T1 - Behandlung fehlender milchabsonderung beim menschen - Google Patents

Behandlung fehlender milchabsonderung beim menschen

Info

Publication number
ATE184489T1
ATE184489T1 AT91916584T AT91916584T ATE184489T1 AT E184489 T1 ATE184489 T1 AT E184489T1 AT 91916584 T AT91916584 T AT 91916584T AT 91916584 T AT91916584 T AT 91916584T AT E184489 T1 ATE184489 T1 AT E184489T1
Authority
AT
Austria
Prior art keywords
treatment
higf
lack
human beings
relates
Prior art date
Application number
AT91916584T
Other languages
English (en)
Inventor
Peter Gluckman
Stella Ruth Milsom
Original Assignee
Pharmacia & Upjohn Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pharmacia & Upjohn Ab filed Critical Pharmacia & Upjohn Ab
Application granted granted Critical
Publication of ATE184489T1 publication Critical patent/ATE184489T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/27—Growth hormone [GH] (Somatotropin)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/475—Quinolines; Isoquinolines having an indole ring, e.g. yohimbine, reserpine, strychnine, vinblastine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/25—Growth hormone-releasing factor [GH-RF] (Somatoliberin)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/30—Insulin-like growth factors (Somatomedins), e.g. IGF-1, IGF-2
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/14—Drugs for genital or sexual disorders; Contraceptives for lactation disorders, e.g. galactorrhoea
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
AT91916584T 1990-08-03 1991-07-19 Behandlung fehlender milchabsonderung beim menschen ATE184489T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
NZ23476690 1990-08-03

Publications (1)

Publication Number Publication Date
ATE184489T1 true ATE184489T1 (de) 1999-10-15

Family

ID=19923318

Family Applications (1)

Application Number Title Priority Date Filing Date
AT91916584T ATE184489T1 (de) 1990-08-03 1991-07-19 Behandlung fehlender milchabsonderung beim menschen

Country Status (13)

Country Link
US (1) US5276014A (de)
EP (1) EP0652767B1 (de)
JP (1) JP3074302B2 (de)
AT (1) ATE184489T1 (de)
AU (1) AU643073B2 (de)
CA (1) CA2086754C (de)
DE (1) DE69131629T2 (de)
DK (1) DK0652767T3 (de)
ES (1) ES2138960T3 (de)
GR (1) GR3032156T3 (de)
IE (1) IE912345A1 (de)
PT (1) PT98563B (de)
WO (1) WO1992002245A1 (de)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ243071A (en) * 1992-06-08 1994-09-27 Kabi Pharmacia Ab Igf-2 (or analogue) compositions for pharmaceutical uses
CN1174504A (zh) * 1993-11-09 1998-02-25 麦克公司 促进生长激素释放的哌啶、吡咯烷和六氢－1h－吖庚因
AU3620995A (en) * 1994-09-21 1996-04-09 Chiron Corporation Method of treating hypertension in pregnant mammals
WO1996019235A1 (en) * 1994-12-21 1996-06-27 Auckland Uniservices Limited Enhancement of fetal growth by administration of insulin-like growth factor-1(igf-1)
GR1007178B (el) * 1995-02-22 2011-01-31 Πετρομανωλακης Εμμ. Πρωραιος αγωγος σκαφους με διατομην αεροτομης.
US5622932A (en) * 1995-05-05 1997-04-22 Eli Lilly And Company IGF-1 superagonists

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3853833A (en) * 1971-04-27 1974-12-10 Hormone Res Foundation Synthetic human growth-promoting and lactogenic hormones and method of producing same
BG49718A3 (en) * 1983-07-15 1992-01-15 Bio Technology General Corp Method for preparing of polypeptid with superoxiddismutasne activitty
EP0193917A3 (de) * 1985-03-06 1987-09-23 American Cyanamid Company Wasserdispersible und wasserlösliche Polymerzusammensetzungen für parenterale Anwendung
EP0212531A1 (de) * 1985-08-12 1987-03-04 Syntex (U.S.A.) Inc. Derivat des Rinderwachstumshormon freisetzenden Faktors
US4783524A (en) * 1985-09-17 1988-11-08 Monsanto Company Growth factors
CA1299103C (en) * 1986-03-07 1992-04-21 Robert Joseph Collier Method and compositions for increasing mammary parenchyma
IL86102A (en) * 1987-05-11 1994-04-12 Univ Tulane Alkylated peptides that release growth hormone and their use
FR2622455B1 (fr) * 1987-11-04 1991-07-12 Agronomique Inst Nat Rech Application du facteur de stimulation de la secretion de l'hormone de croissance humaine, de ses fragments actifs et des analogues correspondants, pour augmenter la production laitiere et le poids des nouveau-nes chez les mammiferes
US5089473A (en) * 1988-08-29 1992-02-18 Monsanto Company Somatotropin variants and their use

Also Published As

Publication number Publication date
EP0652767A1 (de) 1995-05-17
IE912345A1 (en) 1992-02-12
CA2086754C (en) 2000-08-29
CA2086754A1 (en) 1992-02-04
AU8510891A (en) 1992-03-02
PT98563B (pt) 1999-01-29
JP3074302B2 (ja) 2000-08-07
ES2138960T3 (es) 2000-02-01
DK0652767T3 (da) 2000-04-03
JPH05509329A (ja) 1993-12-22
EP0652767B1 (de) 1999-09-15
GR3032156T3 (en) 2000-04-27
DE69131629D1 (de) 1999-10-21
US5276014A (en) 1994-01-04
WO1992002245A1 (en) 1992-02-20
DE69131629T2 (de) 2000-03-09
PT98563A (pt) 1992-06-30
AU643073B2 (en) 1993-11-04

Similar Documents

Publication Publication Date Title
EP1201241B8 (de) Zusammensetzungen enthaltend Capsaicin oder Capsaicin Analoge und ein Anästhetikum
ATE204178T1 (de) Methode zur behandlung und vorbeugung von typ-1 diabetis durch orale verabreichung von insulin
ATE203165T1 (de) Behandlung des partiellen wachstumshormon- unempfindlichkeitssyndromes
BG103521A (en) Substituted pyrimidinon and pyridon compounds and methods for their application
IE882091L (en) Pharmaceutical compositions comprising sometostatin¹analogues
BG103780A (en) Antitussive compositions
IT1170214B (it) Composizione farmaceutica per la cura delle arteriopatie periferiche
DK0668077T3 (da) Produkter, som indeholder G-CSF og TNF-bindende protein
MX9701187A (es) Nuevas lactamas naftofusionadas n-substituidas.
ATE184489T1 (de) Behandlung fehlender milchabsonderung beim menschen
HUT57204A (en) Process for producing 4-fluoro-2-///4-methoxy-2-pyridinyl/-methyl/-sulfinyl/-1h-benzimidazol with gastric acid secration-diminishing activity and pharmaceutical compositions containing them
AU567018B2 (en) Prazosin-pirbuterol combination for bronchoduation
IE870577L (en) Topical amide preparation
HUP9903679A2 (hu) Olanzapin alkalmazása bipoláris zavar kezelésére szolgáló gyógyszerkészítmények előállítására
DE69734349D1 (de) Behandlung von knochenleiden mit adrenomedullin
ZA873928B (en) Topical methotrexate preparation for the treatment of hyperproliferative epithelial disease
ATE28384T1 (de) Medizinisches verfahren und zubereitung.

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee